Oxford Immunotec Announces Agreement with Stop TB Partnership – Global Drug Facility (GDF) to Provide Access to the T-SPOT®.TB Test for 100+ TB Burden Countries - T-SPOT.TB Test for Korea
Oxford Immunotec's T-Cell Reagent Kit FDA Approved to Automate TB Detection Solution | Clinical Lab Products
T-SPOT Discovery (Research Use Only) | T cell response to SARS-CoV-2
Oxford Immunotec - Wellington
Kit di reagenti anticorpo - T-Cell Xtend® - Oxford Immunotec Ltd. - da laboratorio / di campioni di sangue
Oxford Immunotec to supply T cell testing for UK COVID-19 vaccine trials
PerkinElmer to acquire Oxford Immunotec - The Oxford Magazine
Oxford Immunotec - Crunchbase Company Profile & Funding
PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
Contattaci
Oxford Immunotec Company Profile: Valuation, Investors, Acquisition | PitchBook
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection